- Tytuł:
- A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma
- Autorzy:
- Źródło:
- In European Journal of Cancer April 2024 201
Czasopismo naukowe